Theoretical and Experimental Studies of Phosphonium Ionic Liquids as Potential Antibacterials of MDR <i>Acinetobacter baumannii</i>

Theoretical and Experimental Studies of Phosphonium Ionic Liquids as Potential Antibacterials of MDR <i>Acinetobacter baumannii</i>

A previously developed model to predict antibacterial activity of ionic liquids against a resistant <i>A. baumannii</i> strain was used to assess activity of phosphonium ionic liquids. Their antioxidant potential was additionally evaluated with newly developed models, which were based on...

Full description

Bibliographic Details
Main Authors:	Larysa O. Metelytsia, Diana M. Hodyna, Ivan V. Semenyuta, Vasyl V. Kovalishyn, Sergiy P. Rogalsky, Kateryna Yu Derevianko, Volodymyr S. Brovarets, Igor V. Tetko
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Antibiotics
Subjects:	phosphonium ionic liquids antibacterial <i>Acinetobacter baumannii</i> antioxidants OCHEM QSAR
Online Access:	https://www.mdpi.com/2079-6382/11/4/491

Similar Items

Structure-Activity Relationship Modeling and Experimental Validation of the Imidazolium and Pyridinium Based Ionic Liquids as Potential Antibacterials of MDR <i>Acinetobacter baumannii</i> and <i>Staphylococcus aureus</i>
by: Ivan V. Semenyuta, et al.
Published: (2021-01-01)

Antibacterial Activity of 1-Dodecylpyridinium Tetrafluoroborate and Its Inclusion Complex With Sulfobutyl Ether-β-Cyclodextrin Against MDR Acinetobacter baumannii Strains
by: Sergiy Rogalsky, et al.
Published: (2023-11-01)

Development and application of in silico models to design new antibacterial 5-amino-4-cyano-1,3-oxazoles against colistin-resistant E. coli strains
by: Ivan Semenyuta, et al.
Published: (2023-12-01)

Computationally Designed AMPs with Antibacterial and Antibiofilm Activity against MDR <i>Acinetobacter baumannii</i>
by: Fahad M. Alsaab, et al.
Published: (2023-09-01)

Acinetobacter Baumannii – Virulence Factors and Epidemiology of Infections
by: Marszalik Anna, et al.
Published: (2021-12-01)

Differential Gene Expression of Efflux Pumps and Porins in Clinical Isolates of MDR <i>Acinetobacter baumannii</i>
by: Khalid I. AlQumaizi, et al.
Published: (2022-03-01)

Frequency of MDR and XDR Strains and Antibiotic Resistance Pattern of Acinetobacter baumannii Clinical Isolates in Sari Hospitals, Iran
by: Maryam Asadi Jouybari, et al.
Published: (2020-09-01)

Molecular epidemiology of multiple drug resistant Acinetobacter baumannii from a major teaching hospital in Malaysia
by: Moghaddam, Mohammad Reza Babaei
Published: (2016)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020-04-01)

Gastrointestinal Colonization of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: What Is the Implication for Infection Control?
by: Shuk-Ching Wong, et al.
Published: (2022-09-01)

Identification of a Family of Glycoside Derivatives Biologically Active against <i>Acinetobacter baumannii</i> and Other MDR Bacteria Using a QSPR Model
by: Francisco José Palacios-Can, et al.
Published: (2023-02-01)

Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) <i>Acinetobacter baumannii</i>
by: Sunil Kumar, et al.
Published: (2021-10-01)

Investigation of the Characteristics of Multidrug-Resistant (MDR) Acinetobacter Baumannii Lytic Phage Isolated from the Intensive Care Unit
by: Behnam Sisakhtpour, et al.
Published: (2019-08-01)

Risk factors and drug resistance of the MDR Acinetobacter baumannii in pneumonia patients in ICU
by: Ren Jichen, et al.
Published: (2019-10-01)

Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs against <i>Acinetobacter baumannii</i>
by: Min Ji Hong, et al.
Published: (2021-05-01)

Independent component analysis reveals 49 independently modulated gene sets within the global transcriptional regulatory architecture of multidrug-resistant Acinetobacter baumannii
by: Nitasha D. Menon, et al.
Published: (2024-02-01)

Pharmacodynamics of colistin against Acinetobacter baumannii
by: Mohd Rasidin, Rashizal Sazli
Published: (2017)

Whole-Genome Sequencing of ST2 <i>A. baumannii</i> Causing Bloodstream Infections in COVID-19 Patients
by: Sabrina Cherubini, et al.
Published: (2022-07-01)

Prevalence of Carbapenem Resistance Genes among <i>Acinetobacter baumannii</i> Isolated from a Teaching Hospital in Taiwan
by: Pai-Wei Su, et al.
Published: (2023-08-01)

Current State of Antimicrobial Treatment of Lower Respiratory Tract Infections Due to Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Marco Merli, et al.
Published: (2023-05-01)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01)

Human Pleural Fluid and Human Serum Albumin Modulate the Behavior of a Hypervirulent and Multidrug-Resistant (MDR) <i>Acinetobacter baumannii</i> Representative Strain
by: Camila Pimentel, et al.
Published: (2021-04-01)

ACINETOBACTER BAUMANNII – VIRULENCE FACTORS AND EPIDEMIOLOGY OF INFECTIONS
by: Anna Marszalik, et al.
Published: (2021-12-01)

Extensive Drug Resistance of Strong Biofilm-Producing <i>Acinetobacter baumannii</i> Strains Isolated from Infections and Colonization Hospitalized Patients in Southern Poland
by: Tomasz Kasperski, et al.
Published: (2023-07-01)

Time-Resolved Transcriptional Profiling of Epithelial Cells Infected by Intracellular <i>Acinetobacter baumannii</i>
by: Nuria Crua Asensio, et al.
Published: (2021-02-01)

QSAR studies and antimicrobial potential of 1,3-thiazolylphosphonium salts
by: M. M. Trush, et al.
Published: (2016-08-01)

Novel Phosphonium-Based Ionic Liquid Electrolytes for Battery Applications
by: Andreas Hofmann, et al.
Published: (2022-07-01)

Safety and Prophylactic Efficacy of Liposome-Based Vaccine against the Drug-Resistant <i>Acinetobacter baumannii</i> in Mice
by: Masood Alam Khan, et al.
Published: (2022-06-01)

Sequential Hypertonic-Hypotonic Treatment Enhances Efficacy of Antibiotic against <i>Acinetobacter baumannii</i> Biofilm Communities
by: Azeza Falghoush, et al.
Published: (2020-11-01)

Recent Progress in Phage Therapy to Modulate Multidrug-Resistant <i>Acinetobacter baumannii</i>, including in Human and Poultry
by: Yan Zhang, et al.
Published: (2022-10-01)

Performance Evaluation of the VITEK2 and Sensititre Systems to Determine Colistin Resistance and MIC for <i>Acinetobacter baumannii</i>
by: Hae-Sun Chung, et al.
Published: (2022-06-01)

Antibiotic Resistance of Acinetobacter baumannii Strains Isolated in 2015-2018 Years
by: Tuncer Ozekinci, et al.
Published: (2020-08-01)

<i>Acinetobacter baumannii</i> Infections in Times of COVID-19 Pandemic
by: Karyne Rangel, et al.
Published: (2021-08-01)

A bioinformatic approach to identify confirmed and probable CRISPR–Cas systems in the Acinetobacter calcoaceticus–Acinetobacter baumannii complex genomes
by: Jetsi Mancilla-Rojano, et al.
Published: (2024-04-01)

Novel <i>Acinetobacter baumannii</i> Bacteriophage Aristophanes Encoding Structural Polysaccharide Deacetylase
by: Olga Yu. Timoshina, et al.
Published: (2021-08-01)

Acinetobacter Baumannii Phages: Past, Present and Future
by: Qihang Tu, et al.
Published: (2023-03-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01)

On the reactivity of triphenylphosphoranylidenesuccinic anhydride with nitrogen nucleophiles: a new synthetic route to nitrogen-containing phosphonium salts
by: Cunha Silvio, et al.
Published: (2000-01-01)

Investigation of Antibiotic Susceptibility of Acinetobacter baumannii Isolated from Clinical Specimens (2010-2016)
by: Birol ŞAFAK, et al.
Published: (2016-06-01)